Apeiron Investment Group, Director of Enhanced Group ENHA, has filed 6 purchases and 5 sales on the open market. The latest trade was on 05/07.

AG

AG

Apeiron Investment Group

Director

Company

Enhanced Group ENHA

First filing

23/02/27

Trades

30 trades

Buys / sales

6 / 5

12-month net buying

No record

Last trade

05/07

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
AB Atai Beckley	Open-market buy	25/08/14	25/08/18	8,675,799 sh	$2.19	$18,999,999.81	+20.5%
AB Atai Beckley	Open-market buy	25/03/24	25/03/24	1,800,000 sh	$1.40	$2,520,000	+4.4%
AB Atai Beckley	Open-market buy	25/02/14	25/02/19	10,835,718 sh	$2.10	$22,755,007.8	+36.5%
BI Bionomics	Open-market sale	24/10/02–24/10/04	24/10/07	272,070 sh3 trades	$0.30avg.	$82,526.97	−0.3%
Faeth TherapeuticsFTH	Open-market sale	23/06/01	23/06/02	3,441,661 sh2 trades	$1.58avg.	$5,437,824.38	−100.0%
AB Atai Beckley	Open-market buy	23/03/29	23/03/29	1,214,297 sh	$1.32	$1,602,872.04	+3.9%
Faeth TherapeuticsFTH	Open-market buy	23/02/23	23/02/27	2,200 sh2 trades	$1.61avg.	$3,542	+0.1%